Dataset Information

In Vivo Kinetics and Biotransformation of Aflatoxin B₁ in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method.

ABSTRACT: The in vivo kinetics of aflatoxin B₁ (AFB₁) and its carry-over as aflatoxin M₁ (AFM₁) in milk as well as the toxin loads in the tissue of dairy cows were assessed through a repetitive feeding trial of an AFB₁-contaminated diet of 4 μg kg^-1 body weight (b.w.) for 13 days. This was followed by a clearance period that ended with a single dose trial of an AFB₁-contaminated diet of 40 μg kg^-1 b.w. An ultra-high performance liquid chromatography tandem mass spectrometry method was developed and successfully validated by the determination of linearity (R ² ≥ 0.990), sensitivity (lower limit of quantification, 0.1-0.2 ng ml^-1), recovery (79.5-111.2%), and precision relative standard deviation (RSD) ≤14.7%) in plasma, milk, and various tissues. The repetitive ingestion of AFB₁ indicated that the biotransformation of AFB₁ to AFM₁ occurred within 48 h, and the clearance period of AFM₁ in milk was not more than 2 days. The carry-over rate of AFM₁ in milk during the continuous ingestion experiment was in the range of 1.15-2.30% at a steady state. The in vivo kinetic results indicated that AFB₁ reached a maximum concentration of 3.8 ± 0.9 ng ml^-1 within 35.0 ± 10.2 min and was slowly eliminated from the plasma, with a half-life time (T_1/2) of 931.1 ± 30.8 min. Meanwhile, AFM₁ reached a plateau in plasma (0.5 ± 0.1 ng ml^-1) at 4 h after the ingestion. AFB₁ was found in the heart, spleen, lungs, and kidneys at concentrations of 1.6 ± 0.3, 4.1 ± 1.2, 3.3 ± 0.9 and 5.6 ± 1.4 μg kg^-1, respectively. AFM₁ was observed in the spleen and kidneys at concentrations of only 0.7 ± 0.2 and 0.8 ± 0.1 μg kg^-1, respectively. In conclusion, the in vivo kinetics and biotransformation of AFB₁ in dairy cows were determined using the developed UHPLC-MS/MS method, and the present findings could be helpful in assessing the health risks to consumers.

SUBMITTER: Guo W

PROVIDER: S-EPMC8740645 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

In Vivo Kinetics and Biotransformation of Aflatoxin B1 in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method.

Guo Wenbo W Fan Zhichen Z Fan Kai K Meng Jiajia J Nie Dongxia D Tangni Emmanuel K EK Li Zenghe Z Zhao Zhihui Z Han Zheng Z

Frontiers in chemistry 20211224

The in vivo kinetics of aflatoxin B1 (AFB1) and its carry-over as aflatoxin M1 (AFM1) in milk as well as the toxin loads in the tissue of dairy cows were assessed through a repetitive feeding trial of an AFB1-contaminated diet of 4 μg kg-1 body weight (b.w.) for 13 days. This was followed by a clearance period that ended with a single dose trial of an AFB1-contaminated diet of 40 μg kg-1 b.w. An ultra- ...[more]

PMID: 35004625

Similar Datasets

Project description:The study applied a targeted metabolomics approach that uses a direct injection and tandem mass spectrometry (DI-MS/MS) coupled with a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based metabolomics of plasma to evaluate the effects of supplementing clay with or without Saccharomyces cerevisiae fermentation product (SCFP) on the metabolic status of dairy cows challenged with aflatoxin B1. Eight healthy, lactating, multiparous Holstein cows in early lactation (64 ± 11 DIM) were randomly assigned to one of four treatments in a balanced 4 × 4 duplicated Latin square design with four 33 d periods. Treatments were control, toxin (T; 1725 µg aflatoxin B1 (AFB1)/head/day), T with clay (CL; 200 g/head/day), and CL with SCFP (YEA; 35 g of SCFP/head/day). Cows in T, CL, and YEA were dosed with aflatoxin B1 (AFB1) from days 26 to 30. The sequestering agents were top-dressed from day 1 to 33. On day 30 of each period, 15 mL of blood was taken from the coccygeal vessels and plasma samples were obtained from blood by centrifugation and analyzed for metabolites using a kit that combines DI-MS/MS with LC-MS/MS-based metabolomics. The data were analyzed using the GLIMMIX procedure of SAS. The model included the effects of treatment, period, and random effects of cow and square. Significance was declared at p ≤ 0.05. Biomarker profiles for aflatoxin ingestion in dairy cows fed no sequestering agents were determined using receiver-operator characteristic (ROC) curves, as calculated by the ROCCET web server. A total of 127 metabolites such as amino acids, biogenic amines, acylcarnitines, glycerophospholipids, and organic acids were quantified. Compared with the control, T decreased (p < 0.05) plasma concentrations of alanine, leucine, and arginine and tended to decrease that of citrulline. Treatment with CL had no effects on any of the metabolites relative to the control but increased (p ≤ 0.05) concentrations of alanine, leucine, arginine, and that of citrulline (p = 0.07) relative to T. Treatment with YEA resulted in greater (p ≤ 0.05) concentrations of aspartic acid and lysine relative to the control and the highest (p ≤ 0.05) plasma concentrations of alanine, valine, proline, threonine, leucine, isoleucine, glutamic acid, phenylalanine, and arginine compared with other treatments. The results of ROC analysis between C and T groups revealed that the combination of arginine, alanine, methylhistidine, and citrulline had sufficient specificity and sensitivity (area under the curve = 0.986) to be excellent potential biomarkers of aflatoxin ingestion in dairy cows fed no sequestering agents. This study confirmed the protective effects of sequestering agents in dairy cows challenged with aflatoxin B1.

Project description:A fast, accurate and reliable ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for simultaneous quantification of ivermectin (IVER), doramectin (DORA), and moxidectin (MOXI) in bovine plasma. A priority for sample preparation was the eradication of possible infectious diseases to avoid travel restrictions. The sample preparation was based on protein precipitation using 1% formic acid in acetonitrile, followed by Ostro® 96-well plate pass-through sample clean-up. The simple and straightforward procedure, along with the short analysis time, makes the current method unique and suitable for a large set of sample analyses per day for PK studies. Chromatographic separation was performed using an Acquity UPLC HSS-T3 column, with 0.01% acetic acid in water and methanol, on an Acquity H-Class ultra-high performance liquid chromatograph (UHPLC) system. The MS/MS instrument was a Xevo TQ-S® mass spectrometer, operating in the positive electrospray ionization mode and two multiple reaction monitoring (MRM) transitions were monitored per component. The MRM transitions of m/z 897.50 > 753.4 for IVER, m/z 921.70 > 777.40 for DORA and m/z 640.40 > 123.10 for MOXI were used for quantification. The method validation was performed using matrix-matched calibration curves in a concentration range of 1 to 500 ng/mL. Calibration curves fitted a quadratic regression model with 1/x2 weighting (r ≥ 0.998 and GoF ≤ 4.85%). Limits of quantification (LOQ) values of 1 ng/mL were obtained for all the analytes, while the limits of detection (LOD) were 0.02 ng/mL for IVER, 0.03 ng/mL for DORA, and 0.58 ng/mL for MOXI. The results of within-day (RSD < 6.50%) and between-day (RSD < 8.10%) precision and accuracies fell within acceptance ranges. No carry-over and no peak were detected in the UHPLC-MS/MS chromatogram of blank samples showing good specificity of the method. The applicability of the developed method was proved by an analysis of the field PK samples.

Dataset Information

In Vivo Kinetics and Biotransformation of Aflatoxin B₁ in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method.

Publications

<i>In Vivo</i> Kinetics and Biotransformation of Aflatoxin B<sub>1</sub> in Dairy Cows Based on the Establishment of a Reliable UHPLC-MS/MS Method.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets